INVESTORS

Investors and Commercial Opportunities

Partner With Us

AMELIE is developing a breakthrough regenerative medicine platform with significant commercial potential in a rapidly growing global market. We are actively seeking partners to help accelerate translation, scale-up and future adoption.

We welcome engagement from:

  • Biotechnology and pharmaceutical companies seeking innovative cell therapy platforms
  • Medical device and advanced therapy medicinal product developers
  • Life sciences and regenerative medicine investors
  • Strategic partners in translational development and commercialisation

 

Shape the Future of Regenerative Medicine
Contact the AMELIE team below to explore partnership and investment opportunities